scholarly article | Q13442814 |
P50 | author | Darrick Carter | Q30347951 |
Steven G Reed | Q89520964 | ||
P2093 | author name string | Afzal A Siddiqui | |
Gul Ahmad | |||
Loc Le | |||
Weidong Zhang | |||
Workineh Torben | |||
Raymond T Damian | |||
Gary L White | |||
Roman F Wolf | |||
Souvik Karmakar | |||
David W Carey | |||
Mayeen U Alam | |||
P2860 | cites work | Neglected tropical diseases in sub-saharan Africa: review of their prevalence, distribution, and disease burden | Q21092296 |
A research agenda for helminth diseases of humans: The problem of helminthiases | Q21144498 | ||
A research agenda for helminth diseases of humans: Intervention for control and elimination | Q21562256 | ||
Schistosomiasis vaccines | Q24598949 | ||
Preclinical prophylactic efficacy testing of Sm-p80-based vaccine in a nonhuman primate model of Schistosoma mansoni infection and immunoglobulin G and E responses to Sm-p80 in human serum samples from an area where schistosomiasis is endemic | Q24635389 | ||
Prime-boost and recombinant protein vaccination strategies using Sm-p80 protects against Schistosoma mansoni infection in the mouse model to levels previously attainable only by the irradiated cercarial vaccine | Q24655529 | ||
Therapeutic cancer vaccines: past, present, and future | Q26863283 | ||
Schistosomiasis | Q28215200 | ||
Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review | Q28477145 | ||
Human schistosomiasis | Q29619142 | ||
Resistance against Schistosoma mansoni induced by immunization of mice with cryopreserved schistosomula | Q67433061 | ||
Characterization of Ca(2+)-dependent neutral protease (calpain) from human blood flukes, Schistosoma mansoni | Q70622173 | ||
Characterization of a C3 receptor on the envelope of Schistosoma mansoni | Q72651315 | ||
Resistance to re-infection after exposure to normal and attenuated schistosome parasites in the baboon model | Q33222727 | ||
Trick or treat: the role of vaccines in integrated schistosomiasis control | Q33346303 | ||
Elimination of Schistosoma mansoni Adult Worms by Rhesus Macaques: Basis for a Therapeutic Vaccine? | Q33372341 | ||
Parasites and poverty: the case of schistosomiasis | Q33615662 | ||
The baboon as a non-human primate model of human schistosome infection | Q33771826 | ||
Vaccination with calpain induces a Th1-biased protective immune response against Schistosoma japonicum | Q34005663 | ||
Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine | Q34071134 | ||
Enhanced protective efficacy of a chimeric form of the schistosomiasis vaccine antigen Sm-TSP-2. | Q34201141 | ||
Time to set the agenda for schistosomiasis elimination | Q34266980 | ||
The immune response to schistosome antigens in formerly infected travelers | Q34422358 | ||
Does mass drug administration for the integrated treatment of neglected tropical diseases really work? Assessing evidence for the control of schistosomiasis and soil-transmitted helminths in Uganda | Q34510642 | ||
Evaluation of the health-related quality of life of children in Schistosoma haematobium-endemic communities in Kenya: a cross-sectional study | Q34626132 | ||
Previous or ongoing schistosome infections do not compromise the efficacy of the attenuated cercaria vaccine | Q34721343 | ||
Research on calpain of Schistosoma japonicum as a vaccine candidate | Q35744769 | ||
Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach? | Q36056272 | ||
Trichuris muris: a model of gastrointestinal parasite infection | Q36394382 | ||
Integrated analysis of innate, Th1, Th2, Th17, and regulatory cytokines identifies changes in immune polarisation following treatment of human schistosomiasis | Q36882459 | ||
Experimental vaccines in animal models for schistosomiasis | Q37079841 | ||
Protective and antifecundity effects of Sm-p80-based DNA vaccine formulation against Schistosoma mansoni in a nonhuman primate model | Q37216479 | ||
Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis | Q37315241 | ||
Praziquantel: its use in control of schistosomiasis in sub-Saharan Africa and current research needs. | Q37413446 | ||
Sm-p80-based DNA vaccine formulation induces potent protective immunity against Schistosoma mansoni | Q37450247 | ||
Nucleic acid vaccination with Schistosoma mansoni antioxidant enzyme cytosolic superoxide dismutase and the structural protein filamin confers protection against the adult worm stage | Q37523953 | ||
Th2 immune response against Schistosoma mansoni infection | Q37764539 | ||
Therapeutic vaccines against HIV infection | Q38013505 | ||
Allergen-specific immunotherapy: from therapeutic vaccines to prophylactic approaches. | Q38013789 | ||
Susceptibility or resistance of praziquantel in human schistosomiasis: a review | Q38050973 | ||
Th2 responses in schistosomiasis. | Q38058759 | ||
Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines | Q38059150 | ||
New vaccines for neglected parasitic diseases and dengue | Q38098308 | ||
Comparison of the FeKal CON-Trate system with the formalin-ethyl acetate technique for detection of intestinal parasites | Q40203860 | ||
A DNA-prime/protein-boost vaccination regimen enhances Th2 immune responses but not protection following Schistosoma mansoni infection | Q40545484 | ||
Further development of the baboon as a model for acute schistosomiasis | Q40740857 | ||
Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis | Q46480693 | ||
Molecular cloning and sequence analysis of a calcium-activated neutral protease (calpain) from Schistosoma mansoni | Q48198083 | ||
CpG oligonucleotides as adjuvant in therapeutic vaccines against parasitic infections. | Q51972395 | ||
Schistosomiasis | Q56639209 | ||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | therapeutic vaccine | Q105212712 |
P304 | page(s) | 1929-1940 | |
P577 | publication date | 2014-01-16 | |
P1433 | published in | Journal of Infectious Diseases | Q4051141 |
P1476 | title | Use of an Sm-p80-based therapeutic vaccine to kill established adult schistosome parasites in chronically infected baboons | |
P478 | volume | 209 |